Moleculin Biotech, Inc. - Common Stock — 四半期キャッシュフロー (NASDAQ:MBRX) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

総資産 16.93 M21.01 M21.59 M20.35 M22.13 M23.36 M 負債合計 10.95 M20.97 M28.76 M47.27 M7.12 M8.18 M 純資産合計 5.98 M42 K-7.17 M-26.92 M15.01 M15.18 M 負債および純資産合計 16.93 M21.01 M21.59 M20.35 M22.13 M23.36 M 有利子負債合計 —————— 純負債 ——————

ニュース

Moleculin Biotech releases CEO update on leukemia trial

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.54%

Moleculin Biotech株、新株予約権行使契約で急落

Moleculin Biotech stock plunges after warrant exercise agreement

Moleculin Biotech、新株予約権の行使により830万ドルを調達

Moleculin Biotech raises $8.3 million through warrant exercise

Moleculin Biotech株、AML治療薬の臨床試験で有望な結果を示し上昇

Moleculin Biotech stock rises as AML drug trial shows promising results

Moleculin、重要なAML治療試験で有望な初期データを報告

Moleculin reports promising early data in pivotal AML treatment trial

日本での重要特許取得後、Moleculin Biotech株が上昇

Moleculin Biotech stock rises after securing key Japanese patent